The future is here-targeted therapies are coming of age in biliary tract cancers

Chin Clin Oncol. 2023 Jun;12(3):20. doi: 10.21037/cco-23-20. Epub 2023 May 15.

Authors

Daniel Neureiter¹, Matthias Ocker²

Affiliations

¹ Institute of Pathology, Paracelsus Medical University/University Hospital Salzburg (SALK), Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria.
² Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Campus Charité Mitte, Charité University Medicine Berlin, Berlin, Germany; EO Translational Insights Consulting GmbH, Berlin, Germany.

PMID: 37211774
DOI: 10.21037/cco-23-20

No abstract available

Keywords: Biliary tract cancer (BTC); biomarkers; precision medicine; targeted therapy.

Publication types

Editorial

MeSH terms

Bile Duct Neoplasms*
Bile Ducts, Intrahepatic
Biliary Tract Neoplasms* / drug therapy
Cholangiocarcinoma* / drug therapy
Humans
Molecular Targeted Therapy